Skip to main content
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.13
+0.12 (1.50%)
At close: Mar 10, 2026

HKG:2566 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '26 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,9351,620---
Enterprise Value
1,4991,716---
Last Close Price
8.016.56---
PE Ratio
13.4410.98---
PS Ratio
1.351.11---
PB Ratio
1.111.00---
P/TBV Ratio
1.251.00---
P/FCF Ratio
17.2219.10---
P/OCF Ratio
14.7316.06---
EV/Sales Ratio
1.051.18---
EV/EBITDA Ratio
8.338.38---
EV/EBIT Ratio
11.0610.27---
EV/FCF Ratio
13.3420.24---
Debt / Equity Ratio
0.120.080.190.290.28
Debt / EBITDA Ratio
1.150.620.962.701.32
Debt / FCF Ratio
1.841.521.46-15.02
Net Debt / Equity Ratio
-0.25-0.320.050.140.11
Net Debt / EBITDA Ratio
-2.44-2.550.241.290.50
Net Debt / FCF Ratio
-3.88-6.160.36-141.555.61
Asset Turnover
0.750.851.020.94-
Inventory Turnover
1.551.801.741.45-
Quick Ratio
3.963.661.881.621.34
Current Ratio
4.504.132.422.131.87
Return on Equity (ROE)
9.48%11.47%14.39%8.07%-
Return on Assets (ROA)
4.45%6.08%6.81%2.39%-
Return on Invested Capital (ROIC)
8.90%13.13%13.48%5.51%15.36%
Return on Capital Employed (ROCE)
7.20%9.90%14.30%5.40%16.60%
Earnings Yield
6.99%9.11%---
FCF Yield
5.81%5.24%---
Dividend Yield
0.74%0.91%---
Payout Ratio
1.26%--20.04%-
Buyback Yield / Dilution
-13.46%-2.11%---
Total Shareholder Return
-12.72%-1.21%---
Source: S&P Capital IQ. Standard template. Financial Sources.